NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Vara

Vara

Private
BerlinHealthcare & Life Scienceshttps://www.vara.ai/

Last Round

Series B

Oct 29, 2024

Total Funding Raised

$23.7M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Vara is a healthcare technology company that provides an AI-powered software platform for breast cancer screening.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Computer Vision, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

breast cancer screeningmedical imaging AIradiology softwaremammography AIcomputer visionclinical decision supportAI diagnosticshealth techvertical SaaSmedtechAI radiologymedical AISaaSdigital healthAI-powered diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vara Comparables

Compare Vara with similar companies based on industry and business-model similarity.

Vara comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ScreenPoint Medical
91%
Therapixel
91%
Hera-MI
88%

Vara Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 29, 2024
Series A ExtensionOct 25, 2022
Series AJun 2, 2020
SeedJan 1, 2018

Key People

Founding team and executive leadership

Stefan Bunk

Founder CTO

Founding Team

Jonas Muff

CEO Founder

Founding Team

Vara Investors

Notable investors and investment history

Vara investors
InvestorRounds
Think.HealthSeries A, Seed, Series A Extension
EQT FoundationSeries B, Series A Extension
Plug and Play Tech CenterSeries A, Series A Extension
IBB VenturesSeries B
Merantix CapitalSeries A, Seed, Series A Extension, Early Funding
Soleria CapitalSeries A, Series A Extension
VI PartnersSeries B, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Established distribution partners in over 15 countries.

  • Mar 3, 2026

    PRAIM prospective trial involving 463,000 women published.

Vara Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vara Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vara's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerlin
Employee Range55
Year Founded2018
Last FundingOct 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.